First Horizon Corp Makes New Investment in UnitedHealth Group Incorporated $UNH

First Horizon Corp bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 4,196 shares of the healthcare conglomerate’s stock, valued at approximately $1,449,000.

Other large investors have also recently modified their holdings of the company. Brighton Jones LLC raised its holdings in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. Jones Financial Companies Lllp increased its holdings in UnitedHealth Group by 30.1% during the 1st quarter. Jones Financial Companies Lllp now owns 87,961 shares of the healthcare conglomerate’s stock valued at $45,587,000 after purchasing an additional 20,375 shares during the period. Kera Capital Partners Inc. grew its position in shares of UnitedHealth Group by 45.6% in the 2nd quarter. Kera Capital Partners Inc. now owns 728 shares of the healthcare conglomerate’s stock worth $227,000 after buying an additional 228 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. raised its holdings in shares of UnitedHealth Group by 14.3% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 5,689 shares of the healthcare conglomerate’s stock valued at $1,774,000 after acquiring an additional 713 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Brokerages maintain a constructive stance — analysts on average rate UNH a “Moderate Buy,” which supports baseline investor confidence in the business despite headline risk. UnitedHealth Group Incorporated (NYSE:UNH) Given Average Rating of “Moderate Buy” by Brokerages
• Positive Sentiment: Company-funded independent studies (Milliman) claim Medicare Advantage delivers cost savings for the federal government and lower out-of-pocket costs for beneficiaries — a message UnitedHealth is using to defend its MA business model. New Independent Studies: Medicare Advantage Delivers Greater Value to the Federal Government and Beneficiaries than Traditional Medicare
• Positive Sentiment: Market participants and commentators continue to include UNH among healthcare names to watch, reflecting confidence in its scale and membership/margin drivers over the medium term. Final Trades: Capital One, UnitedHealth, Regeneron and Alibaba
• Neutral Sentiment: Sector commentary (healthcare ETFs, MarketBeat) highlights a broader healthcare rebound — a positive backdrop for UNH but not a direct counter to regulatory headlines. This ETF Is Proof That the Healthcare Rebound Is Real (UNH)
• Neutral Sentiment: Post-Q3 coverage and analyst pieces review UNH’s earnings beat and growth profile; fundamentals remain strong but may be overshadowed by policy risk. UnitedHealth (UNH): Buy, sell, or hold post Q3 earnings?
• Negative Sentiment: Senate report and press coverage allege UnitedHealth used aggressive tactics to gather diagnoses that boost Medicare Advantage payments — the primary driver of today’s negative sentiment as it raises risks of fines, repayment, or tighter oversight. Senate report says UnitedHealth used aggressive tactics to boost medicare payments, WSJ reports
• Negative Sentiment: Separate scrutiny over nursing-home practices adds another regulatory/legal angle investors must monitor, increasing uncertainty around reputational and compliance costs. UnitedHealth faces renewed scrutiny into its nursing home practices. What does that mean for UNH stock?

Analysts Set New Price Targets

A number of research analysts have issued reports on UNH shares. UBS Group boosted their price objective on shares of UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a research note on Wednesday, October 29th. Barclays lifted their price target on UnitedHealth Group from $386.00 to $391.00 and gave the company an “overweight” rating in a research report on Monday, January 5th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Finally, Sanford C. Bernstein boosted their price target on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.75.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $340.64 on Tuesday. The firm has a market cap of $308.57 billion, a price-to-earnings ratio of 17.78, a price-to-earnings-growth ratio of 2.08 and a beta of 0.42. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. The business has a 50-day simple moving average of $329.65 and a two-hundred day simple moving average of $321.60.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.15 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s payout ratio is presently 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.